Methanex Announces a 10% Dividend Increase and Its Intention to Initiate a New 10% Share Repurchase Program

Jan 31, 2018 21:32 pm UTC| Business

VANCOUVER, British Columbia, Jan. 31, 2018 -- Methanex Corporation (the “Company”) (TSX:MX) (NASDAQ:MEOH) announced today that its Board of Directors has approved a 10 percent increase in its quarterly dividend to...

MB Financial, Inc. Approves Dividend on its Series C Preferred Stock

Jan 31, 2018 21:30 pm UTC| Business

CHICAGO, Jan. 31, 2018 -- MB Financial, Inc. (the “Company”) (Nasdaq:MBFI) announced today that its Board of Directors has declared a quarterly cash dividend on the Company’s 6.00% Non-Cumulative Perpetual Preferred...

Methanex Reports Higher Fourth Quarter 2017 Results and Increases Dividend by 10%

Jan 31, 2018 21:30 pm UTC| Business

VANCOUVER, British Columbia, Jan. 31, 2018 -- For the fourth quarter of 2017, Methanex (TSX:MX) (NASDAQ:MEOH) reported net income attributable to Methanex shareholders of $68 million ($0.81 per common share on a diluted...

Verizon partners with New York State to deploy high-speed broadband to 15,500 rural households

Jan 31, 2018 21:30 pm UTC| Business

NEW YORK, Jan. 31, 2018 -- Verizon is pleased to announce that it has been awarded $70.7 million in Phase 3 of the New NY Broadband Program. An additional $12 million from the Federal Communications Commission (FCC)...

Murphy USA Inc. Reports Preliminary Fourth Quarter 2017 Results

Jan 31, 2018 21:30 pm UTC| Business

EL DORADO,Ark., Jan. 31, 2018 -- Murphy USA Inc. (NYSE:MUSA), a leading marketer of retail motor fuel products and convenience merchandise, today announced preliminary financial results for the three and twelve months...

MKS Instruments Reports Fourth Quarter and Full Year 2017 Financial Results

Jan 31, 2018 21:30 pm UTC| Business

2017 was a record year in revenue and GAAP and Non-GAAP EPS· Annual revenue increased 30% compared to pro-forma 2016 to a record $1.9 billion· Annual semiconductor revenue increased 45% on a pro-forma basis to a record...

Intellia Therapeutics to Present at February Healthcare Investor Conferences

Jan 31, 2018 21:30 pm UTC| Business

CAMBRIDGE, Mass., Jan. 31, 2018 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will present or host...